Clinical guidelines recommend subtotal colectomy for MLH1 and MSH2 variant carriers due to a higher risk of metachronous CRC, whereas segmental resection is typically sufficient for MSH6 and PMS2 carriers [37]. This evidence concerns the gene MLH1 and colorectal carcinoma.